{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:26:31Z","timestamp":1792697191788,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006678","name":"French Association of Liver Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"National League Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004793","name":"Minist\u00e8re de l'Education Nationale, de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbcan.2025.189361","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:55:16Z","timestamp":1748620516000},"page":"189361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fascin-1 in primary liver cancers, perspectives for targeted therapy"],"prefix":"10.1016","volume":"1880","author":[{"given":"Lydia","family":"Dif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Manaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189361_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2025.189361_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1741-7015-11-52","article-title":"Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis","volume":"11","author":"Tan","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.bbcan.2025.189361_bb0015","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3390\/cancers13225760","article-title":"Fascin in gynecological cancers: an update of the literature","volume":"13","author":"Gupta","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.155079","article-title":"The crucial role of fascin-1 in the pathogenesis, metastasis, and chemotherapeutic resistance of breast cancer","volume":"254","author":"Abdullah","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbcan.2025.189361_bb0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.advms.2023.08.003","article-title":"Fascin in migration and metastasis of breast cancer cells - a review","volume":"68","author":"Izdebska","year":"2023","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.bbcan.2025.189361_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231175733","article-title":"The role of Fascin-1 in human urologic cancers: a promising biomarker or therapeutic target?","volume":"22","author":"Zhang","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2025.189361_bb0035","article-title":"The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0040","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/cancers13112536","article-title":"Emerging role of Fascin-1 in the pathogenesis, diagnosis, and treatment of the gastrointestinal cancers","volume":"13","author":"Ristic","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0045","article-title":"Antagonism between wild-type and mutant \u03b2-catenin controls hepatoblastoma differentiation via fascin-1","volume":"5","author":"Gest","year":"2023","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0050","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.7150\/jca.67977","article-title":"FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189361_bb0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/geno.2000.6156","article-title":"Characterization of human retinal fascin gene (FSCN2) at 17q25: close physical linkage of fascin and cytoplasmic actin genes","volume":"65","author":"Tubb","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2025.189361_bb0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1074\/jbc.M112.427971","article-title":"Molecular mechanism of Fascin function in filopodial formation*","volume":"288","author":"Yang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189361_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cm.21309","article-title":"Filopodia formation by crosslinking of F-actin with fascin in two different binding manners","volume":"73","author":"Aramaki","year":"2016","journal-title":"Cytoskelet. Hoboken NJ"},{"key":"10.1016\/j.bbcan.2025.189361_bb0070","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbamcr.2015.01.003","article-title":"Fascin actin bundling controls podosome turnover and disassembly while cortactin is involved in podosome assembly by its SH3 domain in THP-1 macrophages and dendritic cells","volume":"1853","author":"Van Audenhove","year":"2015","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189361_bb0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cub.2009.12.035","article-title":"The actin-bundling protein Fascin stabilizes actin in invadopodia and potentiates protrusive invasion","volume":"20","author":"Li","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/life12060843","article-title":"Structural analysis of human Fascin-1: essential protein for actin filaments bundling","volume":"12","author":"Chung","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.bbcan.2025.189361_bb0085","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/molecules28031296","article-title":"In silico targeting of Fascin protein for cancer therapy: benchmarking, virtual screening and molecular dynamics approaches","volume":"28","author":"Hassan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2025.189361_bb0090","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1074\/jbc.272.4.2527","article-title":"Identification of an actin binding region and a protein kinase C phosphorylation site on human Fascin *","volume":"272","author":"Ono","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189361_bb0095","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1158\/0008-5472.CAN-07-0929","article-title":"Fascin, a novel target of \u03b2-catenin-TCF signaling, is expressed at the invasive front of human colon cancer","volume":"67","author":"Vignjevic","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189361_bb0100","series-title":"Methods Enzymol","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0076-6879(86)34071-0","article-title":"[3] Isolation of fascin, and actin-bundling protein, and SU45, an actin-severing\/capping protein from sea urchin eggs","author":"Bryan","year":"1986"},{"key":"10.1016\/j.bbcan.2025.189361_bb0105","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1073\/pnas.90.19.9115","article-title":"Fascin, an echinoid actin-bundling protein, is a homolog of the Drosophila singed gene product","volume":"90","author":"Bryan","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189361_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/dna.1994.13.821","article-title":"cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein","volume":"13","author":"Duh","year":"1994","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0167-4781(94)90267-4","article-title":"A vertebrate homolog of the actin-bundling protein fascin","volume":"1219","author":"Holthuis","year":"1994","journal-title":"Biochim. Biophys. Acta BBA - Gene Struct. Expr."},{"key":"10.1016\/j.bbcan.2025.189361_bb0120","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1091\/mbc.E18-08-0500","article-title":"Ena\/VASP processive elongation is modulated by avidity on actin filaments bundled by the filopodia cross-linker fascin","volume":"30","author":"Harker","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbcan.2025.189361_bb0125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/dvdy.186","article-title":"Fascin regulates protrusions and delamination to mediate invasive, collective cell migration in vivo","volume":"249","author":"Lamb","year":"2020","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbcan.2025.189361_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1369\/jhc.7A7353.2007","article-title":"Fascin expression in human embryonic, fetal, and normal adult tissue","volume":"56","author":"Zhang","year":"2008","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"10.1016\/j.bbcan.2025.189361_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cm.20356","article-title":"Fascin1 is dispensable for mouse development but is favorable for neonatal survival","volume":"66","author":"Yamakita","year":"2009","journal-title":"Cell Motil. Cytoskeleton"},{"key":"10.1016\/j.bbcan.2025.189361_bb0140","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1242\/bio.20136031","article-title":"Fascin 1 is dispensable for developmental and tumour angiogenesis","volume":"2","author":"Ma","year":"2013","journal-title":"Biol. Open"},{"key":"10.1016\/j.bbcan.2025.189361_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2009.03.035","article-title":"Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies","volume":"137","author":"Lemaigre","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189361_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00441-008-0683-8","article-title":"Expression of fascin-1, an actin-bundling protein, in migrating hepatoblasts during rat liver development","volume":"334","author":"Hayashi","year":"2008","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbcan.2025.189361_bb0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00795-021-00311-8","article-title":"Fascin expression persists with fibronectin in embryonic rat hepatoblasts","volume":"55","author":"Hayashi","year":"2022","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/labinvest.2011.150","article-title":"Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway","volume":"92","author":"Uyama","year":"2012","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2025.189361_bb0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molmed.2018.02.006","article-title":"Genomic profiling and metabolic homeostasis in primary liver cancers","volume":"24","author":"Gingold","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189361_bb0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccell.2019.07.001","article-title":"A pharmacogenomic landscape in human liver cancers","volume":"36","author":"Qiu","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189361_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189361_bb0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41575-019-0229-4","article-title":"Tumour evolution in hepatocellular carcinoma","volume":"17","author":"Craig","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2016.05.035","article-title":"Genetic profiling of hepatocellular carcinoma using next-generation sequencing","volume":"65","author":"Schulze","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0195","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1349-7006.2011.01910.x","article-title":"Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases","volume":"102","author":"Hayashi","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189361_bb0200","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/MEG.0b013e3283515a18","article-title":"Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma","volume":"24","author":"Huang","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jso.21377","article-title":"Fascin expression in progression and prognosis of hepatocellular carcinoma","volume":"100","author":"Iguchi","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0210","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1038\/s41598-024-60026-5","article-title":"Expression of Fascin-1 and its diagnostic value in liver cancer","volume":"14","author":"Lu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189361_bb0215","doi-asserted-by":"crossref","first-page":"FSO273","DOI":"10.4155\/fsoa-2017-0098","article-title":"Fascin is secreted in male\u2019s serum: results of a pilot study","volume":"4","author":"Porav-Hodade","year":"2018","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.bbcan.2025.189361_bb0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10585-015-9721-6","article-title":"Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers","volume":"32","author":"Elewa","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2025.189361_bb0225","article-title":"Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer","volume":"16","author":"Yang","year":"2017","journal-title":"Genet. Mol. Res. GMR"},{"key":"10.1016\/j.bbcan.2025.189361_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.lungcan.2013.08.017","article-title":"Serological investigation of the clinical significance of fascin in non-small-cell lung cancer","volume":"82","author":"Teng","year":"2013","journal-title":"Lung Cancer Amst. Neth."},{"key":"10.1016\/j.bbcan.2025.189361_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.698862","article-title":"Circulating Fascin 1 as a promising prognostic marker in adrenocortical cancer","volume":"12","author":"Cantini","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clinre.2016.10.011","article-title":"Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma","volume":"41","author":"Chen","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0245","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12935-020-01409-2","article-title":"Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis","volume":"20","author":"Huang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189361_bb0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41419-024-06929-7","article-title":"Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189361_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.peptides.2016.12.005","article-title":"The effects of urotensin II on migration and invasion are mediated by NADPH oxidase-derived reactive oxygen species through the c-Jun N-terminal kinase pathway in human hepatoma cells","volume":"88","author":"Li","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.bbcan.2025.189361_bb0260","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41420-021-00778-5","article-title":"Hypoxia-induced Fascin-1 upregulation is regulated by Akt\/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and hippo\/YAP activation","volume":"7","author":"Pu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189361_bb0265","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-13-3009","article-title":"Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin","volume":"74","author":"Zhao","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189361_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10616-025-00707-9","article-title":"AKT activation participates in Fascin-1-induced EMT in hepatoma cells","volume":"77","author":"Zhao","year":"2025","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bbcan.2025.189361_bb0275","first-page":"1455","article-title":"FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition","volume":"52","author":"Zhang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0280","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41420-021-00778-5","article-title":"Hypoxia-induced Fascin-1 upregulation is regulated by Akt\/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo\/YAP activation","volume":"7","author":"Pu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189361_bb0285","doi-asserted-by":"crossref","first-page":"2185761","DOI":"10.1080\/14756366.2023.2185761","article-title":"WRH-2412 alleviates the progression of hepatocellular carcinoma through regulation of TGF-\u03b2\/\u03b2-catenin\/\u03b1-SMA pathway","volume":"38","author":"Elewa","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189361_bb0290","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.17305\/bb.2024.10367","article-title":"Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma","volume":"24","author":"Albalawi","year":"2024","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.bbcan.2025.189361_bb0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma \u2014 evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOG.0000000000000611","article-title":"Molecular classification of cholangiocarcinoma","volume":"36","author":"Louis","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.humpath.2008.06.029","article-title":"Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis","volume":"40","author":"Iguchi","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0310","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MAJ.0b013e3182707108","article-title":"Differential expression of fascin, E-cadherin and vimentin: proteins associated with survival of cholangiocarcinoma patients","volume":"346","author":"Mao","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bbcan.2025.189361_bb0315","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/labinvest.2009.89","article-title":"Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma","volume":"89","author":"Onodera","year":"2009","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s42003-021-02286-9","article-title":"Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development","volume":"4","author":"Pocaterra","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0325","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1533034615580696","article-title":"Fascin overexpression promotes cholangiocarcinoma RBE cell proliferation, migration, and invasion","volume":"15","author":"Zhao","year":"2016","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2025.189361_bb0330","first-page":"3479","article-title":"Fascin induces epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating Wnt\/\u03b2-catenin signaling","volume":"22","author":"Mao","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.bbcan.2025.189361_bb0335","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41416-020-0911-x","article-title":"Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study","volume":"123","author":"C\u00f6kt\u00fc","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189361_bb0340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.2008-3069","article-title":"Cancer risk among children with very low birth weights","volume":"124","author":"Spector","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbcan.2025.189361_bb0345","series-title":"Pediatr. Liver Tumors","first-page":"15","article-title":"Epidemiology of pediatric liver tumors","author":"Birch","year":"2011"},{"key":"10.1016\/j.bbcan.2025.189361_bb0350","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1074\/jbc.271.21.12632","article-title":"Phosphorylation of human fascin inhibits its actin binding and bundling activities","volume":"271","author":"Yamakita","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189361_bb0355","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.7164\/antibiotics.53.1130","article-title":"Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities","volume":"53","author":"Nakae","year":"2000","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbcan.2025.189361_bb0360","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nature08978","article-title":"Migrastatin analogues target fascin to block tumour metastasis","volume":"464","author":"Chen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189361_bb0365","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/d41586-021-03682-1","article-title":"A virtual drug-screening approach to conquer huge chemical libraries","volume":"601","author":"Deane","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189361_bb0370","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1038\/ncomms8465","article-title":"Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization","volume":"6","author":"Huang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189361_bb0375","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jmb.2018.03.009","article-title":"Structural insights into the induced-fit inhibition of Fascin by a small-molecule inhibitor","volume":"430","author":"Huang","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0380","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/cancers12082287","article-title":"Anti-metastasis Fascin inhibitors decrease the growth of specific subtypes of cancers","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2021.07.025","article-title":"Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression","volume":"518","author":"Lin","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189361_bb0390","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2019.01.020","article-title":"Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis","volume":"153","author":"McGuire","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0395","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bmcl.2019.01.035","article-title":"Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents","volume":"29","author":"Francis","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2025.189361_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.719949","article-title":"Potential inhibitors of Fascin from a database of marine natural products: a virtual screening and molecular dynamics study","volume":"9","author":"Lin","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbcan.2025.189361_bb0405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/dmm.008243","article-title":"A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions","volume":"6","author":"Kraft","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbcan.2025.189361_bb0410","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s12276-020-0389-x","article-title":"New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells","volume":"52","author":"Alburquerque-Gonz\u00e1lez","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189361_bb0415","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/cancers13040861","article-title":"The FDA-approved antiviral Raltegravir inhibits Fascin1-dependent invasion of colorectal tumor cells in vitro and in vivo","volume":"13","author":"Alburquerque-Gonz\u00e1lez","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0420","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189361_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0430","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0435","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1523-1747.2000.00112.x","article-title":"Expression of the actin-bundling protein Fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation","volume":"115","author":"Ross","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0440","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.166.1.338","article-title":"Fascin is involved in the antigen presentation activity of mature dendritic Cells1","volume":"166","author":"Al-Alwan","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0445","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.1001667","article-title":"Fascin1 promotes cell migration of mature dendritic cells","volume":"186","author":"Yamakita","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108948","article-title":"Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity","volume":"35","author":"Wang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189361_bb0455","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3390\/cancers14112738","article-title":"Inhibitors of the actin-bundling protein Fascin-1 developed for tumor therapy attenuate the T-cell stimulatory properties of dendritic cells","volume":"14","author":"Zeyn","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0460","doi-asserted-by":"crossref","first-page":"5318729","DOI":"10.1155\/2019\/5318729","article-title":"Anti-invasion and antimetastatic effects of porcine recombinant NK-lysin on SMMC-7721 human hepatocellular carcinoma cells","volume":"2019","author":"Fan","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbcan.2025.189361_bb0465","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijbiomac.2019.08.212","article-title":"Recombinant porcine NK-lysin inhibits the invasion of hepatocellular carcinoma cells in vitro","volume":"140","author":"Khan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0470","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189361_bb0475","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijmm.2022.5206","article-title":"Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (review)","volume":"51","author":"Thapa","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189361_bb0480","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3892\/or.2017.5549","article-title":"miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2025.189361_bb0485","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1007\/s10620-015-3706-9","article-title":"MicroRNA-145 and MicroRNA-133a inhibited proliferation, migration, and invasion, while promoted apoptosis in hepatocellular carcinoma cells via targeting FSCN1","volume":"60","author":"Wang","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbcan.2025.189361_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258998","article-title":"1,8 Cineole and Ellagic acid inhibit hepatocarcinogenesis via upregulation of MiR-122 and suppression of TGF-\u03b21, FSCN1, Vimentin, VEGF, and MMP-9","volume":"17","author":"Abdallah","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189361_bb0495","first-page":"1805","article-title":"Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization","volume":"28","author":"Van Audenhove","year":"2014","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0500","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230376","article-title":"A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation","volume":"14","author":"Burgess","year":"2024","journal-title":"Open Biol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0505","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0510","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0515","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3390\/cancers13225760","article-title":"Fascin in gynecological cancers: an update of the literature","volume":"13","author":"Gupta","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0520","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/cancers13112536","article-title":"Emerging role of Fascin-1 in the pathogenesis, diagnosis, and treatment of the gastrointestinal cancers","volume":"13","author":"Ristic","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189361_bb0525","article-title":"The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189361_bb0530","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79283","article-title":"Nuclear fascin regulates cancer cell survival","volume":"11","author":"Lawson","year":"2022","journal-title":"eLife"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:09:48Z","timestamp":1762290588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0304419X25001039"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189361","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fascin-1 in primary liver cancers, perspectives for targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189361"}}